POSLUMA (Class 99)

The trademark application number 8064557 is currently marked as "New Application" in the official trademark registry.

The trademark application number 8064557 is owned by Blue Earth Diagnostics Limited.

Trademark application number 8064557 is filed under Class 99, which relates to the specified goods and services.

Trademark application number 8064557 relates to "[CLASS : 1] Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use. [CLASS : 5] Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging. [CLASS : 42] Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services.".